XtalPi

AI-driven drug discovery and chemical automation.

📋 Overview of XtalPi

Founding Year

2015

Estimated Funding

$0000

Size

$0000

Locations

Cambridge

Primary Industry

Biotechnology, Industry

📙 About XtalPi

XtalPi is a biotech company that provides fully integrated drug discovery solutions and chemical services. Specializing in small-molecule and biologics discovery, it uses its proprietary AI platforms like ID4 and XupremAb to accelerate drug development. The company combines automation, computational chemistry, and solid-state chemistry to support every stage of medicinal research. With high-throughput synthesis and automated crystallization platforms, it streamlines and optimizes drug discovery, helping pharmaceutical companies.

💰 Recent Investors of XtalPi

Morningside Venture Capital, Orbimed, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.